Masahiro Takita

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan et al. · Cancers · 2019 · 291 citations · Full text

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami et al. · Liver Cancer · 2015 · 203 citations · Full text

Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma

Hideki Makinoshima, Masahiro Takita, Shingo Matsumoto et al. · Journal of Biological Chemistry · 2014 · 198 citations · Full text

Pyrimidine Biosynthesis, Metabolic Remodeling, Cancer Biology +19

Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma

Hideki Makinoshima, Masahiro Takita, Koichi Saruwatari et al. · Journal of Biological Chemistry · 2015 · 184 citations · Full text

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study

Kazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara et al. · Cancers · 2019 · 140 citations · Full text